Mealeys

Recent Posts

Pfizer Shareholder Class OK'd By MDL Judge For Disclosures About Celebrex, Bextra
Posted on 3 Apr 2012 by Mealeys

NEW YORK - A New York federal judge overseeing the Pfizer Inc. securities multidistrict litigation on March 29 certified a class of shareholders who allege that their stock value was affected by misstatements and omissions concerning the safety of the... Read More

New Trial Sought After $113M Verdict In Attempted Monopolization Case
Posted on 16 Oct 2013 by Mealeys

MARSHALL, Texas - Becton, Dickinson & Co. (BD) on Oct. 11 moved for judgment as a matter of law or, alternatively, a new trial following a federal jury in Texas' $133,508,014 damage award in favor of Retractable Technologies Inc.(RTI) on its claim... Read More

Drug Companies Tell High Court That Reverse-Payment Settlements Are Lawful
Posted on 26 Feb 2013 by Mealeys

WASHINGTON, D.C. - Several drug companies told the U.S. Supreme Court in their merits briefs on Feb. 21 that the court should analyze antitrust challenges to reverse-payment settlements of patent litigation between the holder of a drug patent and potential... Read More

Sham Litigation Claims Against Biovail Are Settled; Case Against GSK Continues
Posted on 25 Jul 2012 by Mealeys

PHILADELPHIA - Biovail Corp., the manufacturer of the prescription antidepressant drug Wellbutrin XL, reached a $37.5 million settlement on July 23 with direct purchasers who claimed that Biovail illegally conspired to prevent generic versions of the... Read More

Class Is Certified In Blood Reagents Price- Fixing Litigation
Posted on 27 Aug 2012 by Mealeys

PHILADELPHIA - A federal judge in Pennsylvania on Aug. 22 certified a class of direct purchasers of blood reagents on their claims that producers of blood reagents conspired to raise prices and allocate customers in violation of federal antitrust laws... Read More

Dental Implant Maker Enters Class Settlement With Dentists For 'Defective' Implant
Posted on 17 Apr 2013 by Mealeys

LOS ANGELES - Nobel Biocare Holding AG has agreed to settle a class action with American dentists who claim that they were financially harmed when a dental implant failed sooner than warranted, according to an April 15 motion for preliminary approval... Read More

K-V Discovery Solutions Seeks Approval Of $60M Settlement With Hologic Inc.
Posted on 7 Dec 2012 by Mealeys

NEW YORK - Bankrupt pharmaceutical company K-V Discovery Solutions Inc. on Dec. 5 moved in the U.S. Bankruptcy Court for the Southern District of New York for approval of a $60 million settlement with Hologic Inc. that would dispose of Hologic's claims... Read More

Judge Again Finds Dow Breast Implant Settlement Includes Tissue Expanders
Posted on 10 Oct 2013 by Mealeys

DETROIT - On remand from a federal appeals court, the judge overseeing the Dow Corning silicone breast implant settlement on Oct. 8 affirmed her four-year-old ruling that breast tissue expanders are covered by the settlement (In Re: Settlement Facility... Read More

Pharmaceutical Maker Quigley: Reorganization Plan Voting Should Be Extended
Posted on 7 Nov 2012 by Mealeys

NEW YORK - Bankrupt pharmaceutical maker Quigley Co. Inc., a subsidiary of Pfizer Inc., on Nov. 5 moved in the U.S. Bankruptcy Court for the Southern District of New York for an extension of the voting deadline to approve its reorganization plan until... Read More

Bankrupt K-V Discovery Reaches $23.8M Settlement With States, Federal Government
Posted on 29 Aug 2013 by Mealeys

NEW YORK - Bankrupt pharmaceutical company K-V Discovery Solutions Inc. on Aug. 28 reached an agreement under which it will pay the United States and certain states asserting Medicaid claims $23.8 million to settle criminal fines and claims made against... Read More

$150M Settlement Receives Final Approval In Flonase Sham Litigation Case
Posted on 18 Jun 2013 by Mealeys

PHILADELPHIA - A federal judge in Pennsylvania on June 14 granted final approval to a $150 million cash settlement between Flonase manufacturer GlaxoSmithKline PLC (GSK) and a certified class of 33 direct purchasers on the direct purchasers' claims... Read More

Bankruptcy Judge OKs $3M Deal To Settle K-V Discovery Overpricing Claims
Posted on 21 Jun 2013 by Mealeys

NEW YORK - The federal bankruptcy judge presiding over the Chapter 11 proceeding of pharmaceutical company K-V Discovery Solutions Inc. on June 20 granted a motion by bankrupt K-V and approved a $3 million settlement between the company and the State... Read More

High Court Will Consider Whether Reverse-Payment Settlements Are Anti-Competitive
Posted on 7 Dec 2012 by Mealeys

WASHINGTON, D.C. - The Supreme Court today granted the Federal Trade Commission's petition for a writ of certiorari seeking consideration of whether reverse-payment settlements of patent litigation between the holder of a drug patent and generic manufacturers... Read More

High Court Review Of 3rd Circuit's Antitrust Standing Rule Is Denied
Posted on 1 Oct 2012 by Mealeys

WASHINGTON, D.C. - The U.S. Supreme Court on Oct. 1 denied a pharmaceutical drug developer's petition seeking review of a Third Circuit U.S. Court of Appeals ruling that the developer did not have antitrust standing to sue pharmaceutical marketers... Read More

Shareholder Class Certified Against Matrixx Initiatives For Unreported Injuries
Posted on 3 Aug 2012 by Mealeys

PHOENIX - An Arizona federal judge on July 31 certified a national class of people who bought stock in Matrixx Initiatives Inc. from Dec. 22, 2007, and June 15, 2009, and allegedly saw their stock price drop because the company failed to report 800 cases... Read More